Page last updated: 2024-11-07

d-glucaro-delta-lactam

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

D-glucaro-delta-lactam: RN given refers to parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID451784
SCHEMBL ID2792137
MeSH IDM0042222

Synonyms (2)

Synonym
d-glucaro-delta-lactam
SCHEMBL2792137

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" Protection was dosage related, and potentiated with increasing doses, but only when the two drugs were given simultaneously."( Protective effect of D-glucaro-delta-lactam against amino-glycoside-induced nephrotoxicity in rats.
Inouye, S; Koeda, T; Niida, T; Nizato, T; Tsuruoka, T, 1976
)
0.26
"Intramuscular administration of glucarolactam in the form of aminoglycoside salt to guinea-pigs protected the experimental ototoxicity caused by high dosing of aminoglycoside antibiotics."( Effect of glucarolactam on ototoxicity of aminoglycoside antibiotics in guinea-pigs.
Inouye, S; Kitasato, I; Niizato, T; Yokota, M, 1989
)
0.28
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (10)

TimeframeStudies, This Drug (%)All Drugs %
pre-19904 (40.00)18.7374
1990's5 (50.00)18.2507
2000's1 (10.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other11 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]